정신과 외래 진료 환자들의 MMPI-2-RF 타당도 척도와 치료 조기 종결 및 치료 지속 기간 간의 관계
The Relationships among MMPI-2-RF Validity Scales, Premature Termination and Treatment Duration in Psychiatric Outpatients
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives：This study aimed to examine the validity scales of Minnesota Multiphasic Personality Inventory–2 Restructured Form (MMPI-2-RF) in Predicting premature termination and treatment duration in psychiatric outpatients. Methods：The MMPI–2 was administered to 202 patients with psychiatric medication, and its data converted to MMPI-2-RF was used for analysis. An independent t-test used to determine whether there was a difference in validity scales between premature termination group and treatment continued group. Then, logistic regression analysis was performed to determine the degree of effect on premature termination. Moreover, correlation analysis and multiple regression analysis were performed to confirm the relationship between treatment duration and validity scales. Results：The premature termination group showed higher score in variable response inconsistency (Vrin-r), adjustment validity (K-r) and lower score in infrequent responses (F-r) compared to the treatment continued groups. In logistic regression analysis, however, none of MMPI-2-RF validity scales predicted premature termination. Also, it was found that higher K-r score was associated with shorter treatment duration. Conclusion：The study showed that the MMPI-2-RF validity scales can predict whether to continue medication and treatment. Therefore, it is expected that more thorough studies of the attitudes toward treatment with respect to the validity scales provides the opportunity to find patients at high risk of premature treatment prior to medication and to strengthen their motivation for treatment, thereby leading to more effective and lasting treatment.
Abstract
Objectives：This study aimed to examine the validity scales of Minnesota Multiphasic Personality Inventory–2 Restructured Form (MMPI-2-RF) in Predicting premature termination and treatment duration in psychiatric outpatients. Methods：The MMPI–2 was administered to 202 patients with psychiatric medication, and its data converted to MMPI-2-RF was used for analysis. An independent t-test used to determine whether there was a difference in validity scales between premature termination group and treatment continued group. Then, logistic regression analysis was performed to determine the degree of effect on premature termination. Moreover, correlation analysis and multiple regression analysis were performed to confirm the relationship between treatment duration and validity scales. Results：The premature termination group showed higher score in variable response inconsistency (Vrin-r), adjustment validity (K-r) and lower score in infrequent responses (F-r) compared to the treatment continued groups. In logistic regression analysis, however, none of MMPI-2-RF validity scales predicted premature termination. Also, it was found that higher K-r score was associated with shorter treatment duration. Conclusion：The study showed that the MMPI-2-RF validity scales can predict whether to continue medication and treatment. Therefore, it is expected that more thorough studies of the attitudes toward treatment with respect to the validity scales provides the opportunity to find patients at high risk of premature treatment prior to medication and to strengthen their motivation for treatment, thereby leading to more effective and lasting treatment.
참고문헌 (22)
- Blackwell B, "Drug therapy : patient compliance", N Engl J Med, 289, pp.249~252 (1973)
- Cramer JA, "Compliance with medication regimens for mental and physical disorders", Psychiatr Serv, 49, pp.196~201 (1998)
- Lingam R, "Treatment non-adherence in affective disorders", Acta Psychiatr Scand, 105, pp.164~172 (2002)
- 유지희, "일 대학병원 정신과 외래 환자의 약물 순응도에 영향을 미치는 요인", 대한정신약물학회지, 21(1), pp.29~34 (2010), 대한정신약물학회
- 이경욱, "항우울제를 복용 중인 주요 우울증 환자에서 조기 치료 중단율과 위험 요인", 대한정신약물학회지, 17(6), pp.550~556 (2006), 대한정신약물학회
- 김광수, "Risperidone 조기 중단군 및 장기 유지군의 임상적 특성 비교", 신경정신의학, 40(3), pp.487~495 (2001), 대한신경정신의학회
- Ascher-Svanum H, "Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care", J Clin Psychiatry, 67, pp.453~460 (2006)
- Amador XF, "Awareness of illness in schizophrenia", Schizophr Bull, 17, pp.113~132 (1991)
- Nageotte C, "Medication compliance among the seriously mentally ill in a public mental health system", Soc Psychiatry Psychiatr Epidemiol, 32, pp.49~56 (1997)
- Copeland LA, "Treatment adherence and illness insight in veterans with bipolar disorder", J Nerv Ment Dis, 196, pp.16~21 (2008)
- Ben-Porath YS, "Interpreting the MMPI-2-RF" (2012), University of Minnesota Press
- Scholte W, "Predictive validity of the MMPI-2clinical, PSY-5, and RC scales for therapy disruptive behavior", J Psychiatr Pract, 18, pp.420~429 (2012)
- Sellbom M, "Validity of the MMPI-2-RF(restructured form)Lr and Kr scales in detecting underreporting in clinical and nonclinical samples", Psychol Assess, 20, pp.370~376 (2008)
- Mattson C, "Predicting drug course treatment completion using the MMPI-2-RF", Psychol Assess, 24, pp.937~943 (2012)
- Anestis JC, "Reading the road signs : The utility of the MMPI-2 restructured form validity scales in prediction of premature termination", Assessment, 22, pp.279~288 (2015)
- Ben-Porath YS, "Minnesota multiphasic personality inventory-2 restructured form" (2008), University of Minnesota Press
- First MB, "User's guide for the structured clinical interview for DSM-IV axis disorders: SCID-1 clinician version" (1996), American Psychiatric Association
- Han K, "Korean version of MMPI-2-RF Manual" (2011), Maumsarang Co
- Caldwell JR, "The dropout problem in antihypertensive treatment: A pilot study of social and emotional factors influencing a patient’s ability to follow antihypertensive treatment", J Chronic Dis, 22, pp.579~592 (1970)
- Butcher JN, "Personality assessment in treatment planning: Use of the MMPI-2 and BTPI" (2008), Oxford University Press
- McGrath RE, "Identifying psychological contributions to chronic pain complaints with the MMPI-2 : The role of the K scale", J Pers Assess, 70, pp.448~459 (1998)
- Graham JR, "MMPI-2: Assessing personality and psychopathology" (2012), Oxford University Press